Literature DB >> 12771048

GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury?

Luigi Gnudi1, GianCarlo Viberti, Leopoldo Raij, Veronica Rodriguez, Davina Burt, Pedro Cortes, Barry Hartley, Stephen Thomas, Sabrina Maestrini, Gabriella Gruden.   

Abstract

Mesangial matrix deposition is the hallmark of hypertensive and diabetic glomerulopathy. At similar levels of systemic hypertension, Dahl salt-sensitive but not spontaneously hypertensive rats (SHR) develop glomerular hypertension, which is accompanied by upregulation of transforming growth factor beta1 (TGF-beta1), mesangial matrix expansion, and sclerosis. GLUT-1 is ubiquitously expressed and is the predominant glucose transporter in mesangial cells. In mesangial cells in vitro, GLUT-1 overexpression increases basal glucose transport, resulting in excess fibronectin and collagen production. TGF-beta1 has been shown to upregulate GLUT-1 expression. We demonstrated that in hypertensive Dahl salt-sensitive (S) rats fed 4% NaCl (systolic blood pressure [SBP]: 236+/-9 mm Hg), but not in similarly hypertensive SHR (SBP: 230+/-10 mm Hg) or their normotensive counterparts (Dahl S fed 0.5% NaCl, SBP: 145+/-5 mm Hg; and Wistar-Kyoto, SBP: 137+/-3 mm Hg), there was an 80% upregulation of glomerular GLUT-1 protein expression (P< or =0.03). This was accompanied by a 2.7-fold upregulation of TGF-beta1 protein expression in glomeruli of DSH compared with DSN rats (P=0.02). TGF-beta1 expression was not upregulated and did not differ in the glomeruli of Wistar-Kyoto and SHR rats. As an in vitro surrogate of the in vivo hemodynamic stress imposed by glomerular hypertension, we used mechanical stretching of human and rat mesangial cells. We found that after 33 hours of stretching, mesangial cells overexpressed GLUT-1 (40%) and showed an increase in basal glucose transport of similar magnitude (both P< or =0.01), which could be blocked with an anti TGF-beta1-neutralizing antibody. These studies suggest a novel link between hemodynamic and metabolic factors that may cooperate in inducing progressive glomerular injury in conditions characterized by glomerular hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771048     DOI: 10.1161/01.HYP.0000075949.19968.EF

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

1.  Huangqi (astragalus) decoction ameliorates diabetic nephropathy via IRS1-PI3K-GLUT signaling pathway.

Authors:  Xia Chen; Hao Wang; Minqian Jiang; Jie Zhao; Chunling Fan; Yunman Wang; Wen Peng
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming.

Authors:  Pere Llinàs-Arias; Margalida Rosselló-Tortella; Paula López-Serra; Montserrat Pérez-Salvia; Fernando Setién; Silvia Marin; Juan P Muñoz; Alexandra Junza; Jordi Capellades; María E Calleja-Cervantes; Humberto J Ferreira; Manuel Castro de Moura; Marina Srbic; Anna Martínez-Cardús; Carolina de la Torre; Alberto Villanueva; Marta Cascante; Oscar Yanes; Antonio Zorzano; Catia Moutinho; Manel Esteller
Journal:  JCI Insight       Date:  2019-03-07

Review 3.  A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

Authors:  Yashpal S Kanwar; Lin Sun; Ping Xie; Fu-You Liu; Sheldon Chen
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 4.  Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management.

Authors:  Peter N Van Buren; Robert Toto
Journal:  Adv Chronic Kidney Dis       Date:  2011-01       Impact factor: 3.620

5.  Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.

Authors:  Youli Wang; Kathleen Heilig; Thomas Saunders; Andrew Minto; Dilip K Deb; Anthony Chang; Frank Brosius; Carmela Monteiro; Charles W Heilig
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-07

6.  Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.

Authors:  Shizuka Aritomi; Kazumi Niinuma; Tetsuya Ogawa; Tomoyuki Konda; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-08-17       Impact factor: 2.801

Review 7.  The link between Glut-1 and hypertension in diabetic nephropathy.

Authors:  Luigi Gnudi; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

8.  Protein kinase WNK1 promotes cell surface expression of glucose transporter GLUT1 by regulating a Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4)-Rab8A complex.

Authors:  Ana Isabel Mendes; Paulo Matos; Sónia Moniz; Peter Jordan
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

Review 9.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 10.  Metabolic syndrome and associated chronic kidney diseases: nutritional interventions.

Authors:  P Anil Kumar; P Swathi Chitra; G Bhanuprakash Reddy
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.